Involvement of the c-erbB-2 oncogene product in the EGF-induced cell motility of SK-OV-3 ovarian cancer cells

International Journal of Cancer

Volumn 83, Issue 3, 1999, Pages 409-414

  Wiechen, Kai ^a   Karaaslan, Selma ^a   Dietel, Manfred ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; EPIDERMAL GROWTH FACTOR; GENE PRODUCT; ONCOPROTEIN;

ARTICLE; CANCER INVASION; CELL MOTILITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; ONCOGENE C ERB; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

EID: 0032833801     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19991029)83:3<409::aid-ijc18>3.0.co;2-%23     Document Type: Article

References (21)

1. BEERLI, R.R., GRAUS-PORTA, D., WOODS-COOK, K., CHEN, X., YARDEN, Y and HYNES, N.E., Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol. Cell. Biol., 15, 6496-6505 (1995).
2. BERCHUCK, A. AND 12 OTHERS, Overexpression of her-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res., 50, 4087-4091 (1990).
3. CARRAWAY, C.A.C., CARVAJAL, M.E., LI, Y. and CARRAWAY, K.L., Association of p185neu with microfilaments via a large glycoprotein complex in mammary carcinoma microvilli. J. biol. Chem., 268, 5582-5587 (1993).
4. CHRISTEN, R.D., HOM, D.K., PORTER, D.C., ANDREWS, P.A., MACLEOD, C.L., HAFSTROM, L. and HOWELL, S.B., Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin. J. clin. Invest., 86, 1632-1640 (1990).
5. DE CORTE, V., DE POTTER, C., VANDENBERGHE, D., VAN LAEREBEKE, N., AZAM, M., ROELS, H., MAREEL, M. and VANDEKERCKHOVE, J., A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/ HER-2, in human SK-BR-3 mammary cancer cells. J. Cell Sci., 107, 405-416 (1994).
6. DE POTTER, C.R., EECKHOUT, I., SCHELFHOUT, A.-M., GEERTS, M.-L. and ROELS, H.J., Keratinocyte induced chemotaxis in the pathogenesis of Paget's disease of the breast. Histopathology, 24, 349-356 (1994).
7. DE POTTER, C.R. and QUATACKER, J., The p185erbB2 protein is localized on cell organelles involved in cell motility. Clin. exp. Metastasis, 11, 453-461 (1993).
8. GRAUS-PORTA, D., BEERLI, R.R., DALY, J.M. and HYNES, N.E., ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J., 16, 1647-1655 (1997).
9. GRAUS-PORTA, D., BEERLI, R.R. and HYNES, N.E., Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol. cell. Biol., 15, 1182-1191 (1995).
10. HARTMANN, G., WEIDNER, K.M., SCHWARZ, H. and BIRCHMEIER, W., The motility signal of scatter factor/hepatocyte growth factor mediated through the tyrosine kinase met requires intracellular action of ras. J. biol. Chem., 269, 21936-21939 (1994).
11. JONES, J.T., AKITA, R.W. and SLIWKOWSKI, M.X., Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett., 447, 227-231 (1999).
12. KRAUS, M.H., ISSING, W., MIKI, T., POPESCU, N.C. and AARONSON, S.A., Isolation and characterization of ERBB3, a third member of the ERBB/ epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. nat. Acad. Sci. (Wash.), 86, 9193-9197 (1989).
13. MACCAWLEY, L.J., O'BRIEN, P. and HUDSON, L.G., Epidermal growth factor (EGF)-and scatter factor/hepatocyte growth factor (SF/HGF)-mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J. cell. Physiol., 176, 255-265 (1998).
14. MEDEN, H., MARX, D., RATH, W., KRON, M., FATTAHI-MEIBODI, A., HINNEY, B., KUHN, W. and SCHAUER, A., Overexpression of the oncogene c-erbB2 in primary ovarian cancer: evaluation of the prognostic value in a Cox proportional hazards multiple regression. Int. J. Gynecol. Pathol., 13, 45-53 (1994).
15. MYERS, R., SRIVASTAVA, S., OELSCHLEGER, D.K. and GRIZZLE, W.E., Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J. nat. Cancer Inst., 86, 1140-1144(1994).
16. PEAR, W.S., NOLAN, G.P., SCOTT, M.L. and BALTIMORE, D., Production of high-titer helper-free retroviruses by transient transfection. Proc. nat. Acad. Sci. (Wash.), 90, 8392-8396 (1993).
17. PLOWMAN, G.D., CULOUSCU, J.-M., WHITNEY, G.S., GREEN, J.M., CARLTON, G.W., FOY, L., NEUBAUER, M.G. and SHOYAB, M., Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. nat. Acad. Sci. (Wash.), 90, 1746-1750 (1993).
18. TAKAISHI, K., SASAKI, T., KATO, M., YAMOCHI, W., KURODA, S., NAKAMURA, T., TAKEICHI, M. and TAKAI, Y., Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. Oncogene, 9, 273-279 (1994).
19. VOLPERT, O.V., DAMERON, K.M. and BOUCK, N., Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene, 14, 1495-1502 (1997).
20. WIECHEN, K. and DIETEL, M., c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of p185c-erbB-2-overexpressing ovarian carcinoma cells. Int. J. Cancer, 63, 604-608 (1995).
21. YAMAMOTO, T., IKAWA, S., AKIYAMA, T., SEMBA, K., NOMURA, N., MIYAJIMA, N., SAITO, T. and TOYOSHIMA, K., Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature (Lond.), 319, 230-234 (1986).